×

Error message

Unfortunately, at this time the feature that links the CE's from ASHI-U to Learning Builder is currently disabled.  You will have to check the box that you don't have an ABHI Account.  You can complete the Modules on ASHI-U but you will have to manually input the CE's into Learning Builder.  We are so sorry for the inconvenience.  We are working diligently to get this issue resolved as soon as possible.

ASHI Journal Club #5 - HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity. Evidence for the alloimmune basis and prognostic significance of borderline T cell–mediated rejection.

Select a ModuleModule DetailsReview MaterialsEvaluate ModulePrint Certificate

Chris Wiebe, MD, FRCPC Nephrologist University of Manitoba Canadian Blood Services

Annette M. Jackson, PhD, D(ABHI) Associate Professor, Department of Surgery Chief, Clinical Transplantation Immunology Research Director, Clinical Transplantation Immunology Laboratory Duke University

September 16, 2020